Navigation Links
BioImagene Raises $26 M in Expansion Capital
Date:8/19/2008

BioImagene, the leading provider of affordable digital pathology solutions for cancer diagnosis and preclinical research, today announced the closing of a $26 million series D financing round led by Burrill & Company. Ascension Health Ventures, National Healthcare Services and existing investors Artiman Ventures and ICCP Ventures also joined the round with strong support.

CUPERTINO, Calif. (Business Wire EON) August 19, 2008 -- Mr. Yatin Mundkur, Artiman Ventures Partner and BioImagene board member noted "This follow-on investment reaffirms our commitment to the BioImagene team and their innovative products, and reinforces our belief in the enormous growth potential of digital pathology. We are very happy to guide the company through their next phase of future growth."

BioImagene CEO Mohan Uttarwar commented, "This latest infusion of capital from leading investors is a strong vote of confidence in our team, products and strategy. Our goal is to become the dominant player in this space by 2010. We are within range of our target and this funding will help us scale operations to support the rapidly increasing demand for affordable, integrated digital pathology systems. "

Digital pathology is the process of converting entire glass microscope slides into high-resolution, whole-slide digital images that can be viewed, managed and analyzed with a computer instead of a microscope—along with digital pathology management systems that help interpret the information generated from the digitized glass slide.

Digital pathology applications utilizing digital slides are gaining momentum as pathologists can access slide specimens and related data from any location in the world, fostering more efficient laboratory workflow, physician communication, education and research at a reasonable cost.

Investor Information

For more information on Artiman Ventures, please visit www.artimanventures.com

For more information on Ascension Health Ventures, please visit www.ascensionhealthventures.org

For more information on Burrill & Company, please visit www.burrillandco.com

For more information on National Healthcare Services (NHS), please visit www.nationalhealthcareservices.com

For more information on ICCP Ventures, please visit www.iccpventurepartners.com

About BioImagene

BioImagene is a leading provider of total digital pathology solutions for applications including clinical diagnostics and drug discovery. BioImagene products are FDA -cleared for specific clinical applications, and are intended for research use for other applications. www.bioimagene.com.

Read the full story at http://www.prweb.com/releases/bioimagene/ventures/prweb1227644.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Low Vitamin D Raises Womens Hip Fracture Risk
2. NJHA Raises Questions Regarding Horizons Proposal to Convert to For-Profit Health Insurer
3. Stater Bros. Raises $200,000 for the Leukemia & Lymphoma Society
4. Summer Games Swap Raises Questions About Image, Oral Health
5. Dunkin Donuts Event Raises $800,000 for Cancer Research in One Day
6. The Ensign Group, Inc. Reports Second Quarter 2008 Earnings of $.32 per Diluted Share and Raises 2008 Guidance
7. GI Bleeding After Stroke Raises Death Risk
8. Aduromed Closes Restructuring and Raises $3.8 Million of New Equity Capital
9. Genoptix Reports Strong Financial Results for the Second Quarter and Raises Guidance for Full-Year 2008
10. Secondhand Smoke Raises Stroke Risk for Spouses
11. CVS/pharmacy Raises Record-breaking $4.4 Million for ALS Research Through Annual ALS Fundraising Campaign
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
 BioImagene Raises $26 M in Expansion Capital 
(Date:6/24/2016)... ... ... June 19, 2016 is World Sickle Cell Observance Day. In an effort to ... treatments, Serenity Recovery Center of Marne, Michigan, has issued a pain management ... (SCD) is a disorder of the red blood cells, which can cause episodes of ...
(Date:6/24/2016)... ... June 24, 2016 , ... The ... in Dallas that it will receive two significant new grants to support its ... PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists for ...
(Date:6/24/2016)... San Francisco, CA (PRWEB) , ... June 24, ... ... at CitiDent, is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has ... , self-ligating Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , ...
(Date:6/24/2016)... ... ... of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair Minimum Wage’ ... 2020 and then adjusting it yearly to increase at the same rate as the median ... floor does not erode again, and make future increases more predictable. , The company is ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine ... Making in Emergency Medicine conference in Ponte Vedra Beach, FL. The awards honor ... Emergency Medicine Practice and Pediatric Emergency Medicine Practice. , “With this ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
(Date:6/23/2016)... -- Research and Markets has announced the addition ... - Forecast to 2022" report to their offering. ... to date financial data derived from varied research sources to ... potential impact on the market during the next five years, ... of sub markets, regional and country level analysis. The report ...
(Date:6/23/2016)... 23, 2016 Bracket , a leading clinical ... generation clinical outcomes platform, Bracket eCOA (SM) 6.0, at ... 26 – 30, 2016 in Philadelphia , ... Outcome Assessment product of its kind to fully integrate with ... Bracket eCOA 6.0 is a flexible platform for electronic clinical ...
Breaking Medicine Technology: